The bacterium Bordetella pertussis causes """"""""whooping- cough"""""""", a disease which killed thousands of children in the U.S. prior to a widespread vaccination program. The bacterium elaborates several toxins, including """"""""pertussis toxin"""""""", which are involved in the pathogenesis of the disease. A """"""""whole-cell"""""""" vaccine in current use in the U.S. causes severe, potentially permanent, side-reactions. Thus, efforts are underway to develop safer vaccines relying on specific components, such as pertussis toxin. Once developed, a new pertussis vaccine will be given to millions of babies each year. Given the risk of severe side-effects, it behooves us to carefully define this vaccine. Thus, acquiring knowledge concerning pertussis toxin is important to provide a rational basis for its use in the vaccine.
The Specific Aims of this application are designed to yield information helpful for this purpose. In addition, pertussis toxin is a valuable tool is basic research. Thus, the Aims are also designed to improve our understanding of the toxin in basic terms as a scientific tool.
The Aims stem from the recent discovery that adenine nucleotides, detergents, and dithiothreitol directly stimulate the NADase and ADP-ribosyltransferase activities of pertussis toxin. These activities are the basis of its mechanism of action. The application proposes to: 1. Develop an assay of the ADP-ribosyltransferase activity of the toxin using peptide analogs of known pertussis toxin ADP-ribosylation sites. 2. Determine if activating substances separate the subunits of the toxin. If so, then develop new methods for purification of the subunits. 3. Determine if activating substances allow mild conditions to render the toxin incapable of intoxicating cells. Such a process may produce a stable detoxified toxin that is a better immunogen than those produced by other, harsher, procedures. 4. Describe molecular mechanisms of the activation process both in vitro and in intact cells. The approach includes electrophoresis and immunoblotting. 5. Examine other toxins to help establish which activating mechanisms are unique to pertussis, and which are shared by other toxins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI024320-01
Application #
3137249
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1986-12-01
Project End
1989-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Wang, J; Nemoto, E; Kots, A Y et al. (1994) Regulation of cytotoxic T cells by ecto-nicotinamide adenine dinucleotide (NAD) correlates with cell surface GPI-anchored/arginine ADP-ribosyltransferase. J Immunol 153:4048-58
Sugawara, S; Kaslow, H R; Dennert, G (1993) CTX-B inhibits CTL cytotoxicity and cytoskeletal movements. Immunopharmacology 26:93-104
Kaslow, H R; Platler, B W; Blumberg, D A et al. (1992) Detection of antibodies inhibiting the ADP-ribosyltransferase activity of pertussis toxin in human serum. J Clin Microbiol 30:1380-7
Kaslow, H R; Schlotterbeck, J D; Gotto, J (1991) Evaluation of antibodies elicited by immunization with pertussis toxin. Dev Biol Stand 73:143-50
Kaslow, H R; Schlotterbeck, J D; Kenimer, J G (1990) Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin. Infect Immun 58:746-52
Kaslow, H R; Schlotterbeck, J D; Mar, V L et al. (1989) Alkylation of cysteine 41, but not cysteine 200, decreases the ADP-ribosyltransferase activity of the S1 subunit of pertussis toxin. J Biol Chem 264:6386-90
Antwi, D; Youn, J H; Shargill, N S et al. (1988) Regulation of glycogen synthase in muscle and adipose tissue during fasting and refeeding. Am J Physiol 254:E720-5